INJ latest news: negative momentum persists with MACD sell and ADX signaling weak trend

Traders Union
All News
Crypto
Injective slides 8.59% today

Highlights

INJ trades at $5.43, significantly below its MA-20 ($5.96), MA-50 ($7.10), and MA-200 ($11.35), confirming persistent bearish momentum across all timeframes.
Sustained negative signals from the daily MACD, weak ADX, and oscillators (RSI 42.63, CCI -20.02) suggest further downside, with sellers dominating as INJ dropped 8.59% today.
Expected trading for the next week is within $4.90–$5.80, with less than 20% probability of a rally and higher likelihood of continued consolidation or decline if $4.90 support breaks.

Weak seller-led trend as resistance holds and downside signals grow

The closest dynamic resistance for INJ is the Ichimoku Kijun at $6.80, with immediate support defined by nearby intraday lows. Momentum remains negative as the daily MACD signals a strong sell and the ADX indicates a weak, seller-driven trend. RSI at 42.63 and CCI at -20.02 suggest further downside without clear oversold conditions, while Stoch RSI is overbought, highlighting a risk of a short-term bounce within the prevailing bear structure. Bull/Bear Power (BBP) points to modest buyer activity, but sellers continue to dominate intraday moves.

Consolidation likely as sellers dominate and reversal odds remain low

In the short term, the expected trading range for the next week is $4.90 to $5.80, reflecting a volatility band relative to current levels. There is a very low probability (less than 20%) of a meaningful price increase, while signals from weekly and daily oscillators continue to favor further declines. The baseline scenario is for price consolidation within this corridor as sellers retain control; a bullish reversal would require a breakout above $5.80 resistance, while a close below $4.90 support could trigger a move toward new local lows.

Anton Kharitonov, expert at Traders Union, sees consistent downside momentum in Injective (INJ) as the price lingers below all major moving averages and intraday indicators stay bearish. He notes sellers maintain control and there is little evidence of a reversal, with volatility favoring further declines unless resistance at $5.80 is breached. The analyst remains cautious as technical signals continue to favor consolidation or weakness. "Base case is lower for now — unless $5.80 breaks, the risk remains to the downside."

Previously it was reported that Injective remained under pressure, trading below its major moving averages with momentum indicators such as MACD and ADX reaffirming a weak, bearish trend. Resistance was noted at the Kijun line and MA-20, while mixed oscillators — including an overbought Stoch RSI and a weak RSI at 42.89 — suggested ongoing volatility in the face of persistent selling.

Source of Data: INJ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.